AzTrials
AzTrials

FastingNCT04345978

Effects of Fasting Strategies on Postoperative Recovery and Long-term Prognosis in Patients With Colorectal Cancer

A study testing Fasting hours in people with Fasting and Immune Suppression, run by Fudan University at 7 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In 2018, colorectal cancer is the third most common malignant tumor in terms of morbidity and second mortality in the world. Surgical resection is still the main treatment for colorectal cancer.With the introduction of the ERAS, the latest international and domestic guidelines for fasting before surgery all advocate… Read more about this study

Who is it for?
Ages 20 to 70 years
What is being tested?
Fasting hours
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
2,400 participants
Where
7 sitesChina
Study dates
1 Jan 2020to 30 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 20 ~ 70 years old
  • With BMI 20.5-25.0 kg/m2
  • Without any Endocrine and metabolic diseases
  • A stable body weight (±3 kg) for at least 6 months
  • Those diagnosed with colorectal cancer by preoperative pathology or enteroscopy
  • Patients undergoing laparoscopic radical colorectal cancer resection
Show all 11Show fewer
  • ASA grade I-III grade
  • Initial patients have not received any treatment for bowel cancer except neoadjuvant chemotherapy
  • Patients with confirmed and feasible radical resection of colorectal cancer
  • No evidence of distant metastasis before surgery
  • Willing to participate in the research of the subject and agree to follow up regularly

Who cannot join

  • Patients with relapsed colorectal cancer who are going to undergo surgery and re-excision
  • accompanied by other malignant tumors
  • Severe malnourished patients
  • History of systemic metabolism such as diabetes
  • Before surgery, have received other treatments for colorectal cancer (such as local excision, etc.) in addition to neoadjuvant chemotherapy
  • Have a history of immunotherapy before surgery
Show all 11Show fewer
  • Combined with basic diseases of serious heart, lung, brain, kidney and other important organs
  • Combined with severe primary diseases such as severe immune system or hematopoietic system
  • The tumor burden cannot be cured, and there is distant metastasis. Those who intend to undergo palliative surgery
  • People with gastroesophageal reflux disease, difficulty swallowing, intestinal obstruction, or difficulty in airway management
  • People who refuse to participate in the study or cannot receive long-term follow-up

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

China7 sites
  • Department of Biostatistics, School of Public Health, Fudan University,

    Shanghai, Shanghai Municipality, 200032

  • Fudan University Huashan Hospital

    Shanghai, Shanghai Municipality, 200032

  • Fudan University Shanghai Cancer center

    Shanghai, Shanghai Municipality, 200032

  • Fudan University,ZhongShan Hospital

    Shanghai, Shanghai Municipality, 200032

  • Shanghai Changhai Hospital, Naval Medical University,

    Shanghai, Shanghai Municipality, 200032

  • Shanghai First People's Hospital,Shanghai Jiaotong University

    Shanghai, Shanghai Municipality, 200032

  • Shanghai Tongji Hospital,Tongji University

    Shanghai, Shanghai Municipality, 200032

Other trials in China

About this study

Official title: Effects of Different Fasting Strategies in Perioperative Period on Postoperative Recovery, Immune Function, and Long-term Prognosis in Patients With Radical Resection of Colorectal Cancer

In 2018, colorectal cancer is the third most common malignant tumor in terms of morbidity and second mortality in the world. Surgical resection is still the main treatment for colorectal cancer.With the introduction of the ERAS, the latest international and domestic guidelines for fasting before surgery all advocate shortening the fasting time. For example, 2 hours before surgery, oral take cleared fluids, including water, sugar water, fruit juice, tea and black coffee (without milk) is allowed.Solid food can be consumed 4 hours before surgery, and oral diet should be resumed as soon as possible after surgery. Changes in diet, nutritional status, and physical activity are closely related to the incidence of colorectal cancer. Therefore, we believe that the intestine may be very sensitive to different fasting times during the perioperative period. Prolonging the fasting time may improve the prognosis by improving postoperative insulin resistance, reducing inflammation and protecting anti-tumor immune function in patients with colorectal cancer.Prolonged fasting time seems to be contrary to the results of some studies, and whether it is applicable to patients with tumor surgery is unclear. Therefore, there is an urgent need to conduct large-scale, prospective, randomized controlled clinical studies to clarify the most suitable perioperative fasting strategy (including composition, interval, and amount) for cancer patients, which can not only reduce surgical stress and speed up postoperative rehabilitation,reduce postoperative metastasis and recurrence and improve mid- and long-term prognosis.

Read the detailed description

As early as a century ago, Investigators proved that diet restriction can prevent the occurrence of transplanted tumors in mice. Following this milestone, many animal studies (from mice to primates) have confirmed that diet restriction can slow the development of spontaneous tumors and transplanted tumors. A study of macaque monkeys for more than 20 years revealed that restricting diet by 30% can reduce the incidence of tumors by 50%, which makes people see the potential value of restricting diet to humans. However, whether diet restriction can also reduce the incidence of human tumors is not entirely clear. The growth of tumor cells requires a nutrient-rich environment, and the lack of glucose and amino acids caused by diet restrictions is very detrimental to tumor cells. Unlike normal cells, tumor cells mainly rely on glycolysis (Warburg effect) rather than energy and biosynthetic precursors provided by oxidative phosphorylation for proliferation. These characteristics make tumor cells extremely sensitive to changes in the surrounding environment, which is called differential stress sensitization (DSS).Investigators found that the use of low sugar and low serum in a cell model to simulate periodic fasting can enhance the sensitivity of human or animal tumor cells to doxorubicin and cyclophosphamide, and also found that they were transplanted subcutaneously in mice Melanoma or breast cancer, diet combined with chemotherapy is better than chemotherapy alone; in the mouse metastatic neuroblastoma model, fasting before high-dose chemotherapy can successfully reduce the toxic side effects of chemotherapy drugs and reduce metastasis and prolong the tumor-free survival. Surgery and stress are twin brothers. Surgical resection, blood flow blockage, ischemia-reperfusion injury, tissue damage, local inflammatory factor release, and changes in systemic neuroendocrine and metabolism all affect blood flow, blood coagulation, and immune function. Investgators found restricted diet can reduce the inflammatory response after myocardial ischemia-reperfusion injury in mice. Many animal experiments have confirmed that perioperative fasting can effectively protect the liver, kidneys, and brain from organ damage. The specific mechanism may be related to fasting increasing antioxidant enzyme activity, reducing insulin-like growth factor-1 (IGF-1), and activating the autophagy pathway. Similar to chemotherapy, there is currently no randomized clinical controlled study to evaluate the impact of individualized perioperative dietary regimens (such as restricted diet) on the prognosis of tumor surgery.

In 2018, colorectal cancer is the third most common malignant tumor in terms of morbidity and second mortality in the world. Surgical resection is still the main treatment for colorectal cancer.With the introduction of the ERAS, the latest international and domestic guidelines for fasting before surgery all advocate shortening the fasting time. For example, 2 hours before surgery, oral take cleared fluids, including water, sugar water, fruit juice, tea and black coffee (without milk) is allowed.Solid food can be consumed 6 hours before surgery, and oral diet should be resumed as soon as possible after surgery. Changes in diet, nutritional status, and physical activity are closely related to the incidence of colorectal cancer. Therefore, we believe that the intestine may be very sensitive to different fasting times during the perioperative period. Prolonging the fasting time may improve the prognosis by improving postoperative insulin resistance, reducing inflammation and protecting anti-tumor immune function in patients with colorectal cancer.Prolonged fasting time seems to be contrary to the results of some studies, and whether it is applicable to patients with tumor surgery is unclear. Therefore, there is an urgent need to conduct large-scale, prospective, randomized controlled clinical studies to clarify the most suitable perioperative fasting strategy (including composition, interval, and amount) for cancer patients, which can not only reduce surgical stress and speed up postoperative rehabilitation,reduce postoperative metastasis and recurrence and improve mid- and long-term prognosis.

Being tested
Fasting hours
Keywords
Fasting, Immune Suppression, Survival, Immune metabolism
Medical subject headings
Fasting, Colorectal Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fasting hoursBehavioural

    Normal Fasting hours before CRC surgery for 8 hours and feeding 8 hours after surgery; Prolong fasting hours before CRC surgery for 24 hours and feeding 24 hours after surgery.

Study groups in NCT04345978
Study groupRoleWhat they receive
Normal FastingPlacebo comparatorThe patient starts fasting 8 hours before the operation,and does not take any solid or liquid foods and nutrients during the fasting process.The fasting period does not strictly limit the consumption of pure water,After surgery 8 hours,the patients was allowed to feeding.
Receives: Behavioral: Fasting hours
Prolong FastingExperimentalThe patient starts fasting 24 hours before the operation, and does not take any solid or liquid foods and nutrients during the fasting process. The fasting period does not strictly limit the consumption of pure water.After surgery 24 hours,the patients was allowed to feeding.
Receives: Behavioral: Fasting hours

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Disease-free Survival

    Defined and calculated as the time from the date of surgery to the first time of colon cancer recurrence or metastasis or cancer-related death

    Measured: During 2 years after surgery

Secondary outcomes (11)
  1. Overall Survival

    Defined and calculated as the time from the date of surgery to the first time of Colon cancer recurrence or metastasis or cancer-related death

    Measured: During 2 years after surgery

  2. Postoperative pain score and side effects of patient-controlled analgesia

    Assessed with visual analogue score ( 0 is no pain and 10 is the most severe pain)

    Measured: During the first 48 hours after surgery

  3. Incidence of delirium

    Assessed for delirium using the 3D-CAM instrument

    Measured: During the first 1 week after surgery

  4. Length of stay in hospital after surgery and total costs after surgery

    Length of stay in hospital after surgery and total costs after surgery

    Measured: During the first 30 days after surgery

  5. Return of bowel function

    Measured by the time of first flatus

    Measured: During the first 30 days after surgery

  6. Neutrophil to Lymphocyte Ratio,LMR,SII

    Neutrophil to Lymphocyte Ratio,Lymphocyte to Monocyte ratio,Symstem Imflammatory Index

    Measured: During the first24、48 and 72 hours after surgery

  7. Serum CA19-9 、CA125、CEA、CA72-4、CA242、AFP、CA15-3、CA50 levels

    Tumor Biomaker Level

    Measured: During 2 years after surgery

  8. Recovery Parameter

    Q40 scale score

    Measured: During the first24、48 and 72 hours after surgery

  9. T Lymphocyte cell count

    T lymphocyte cell count before fasting and after fasting

    Measured: During the first24、48 and 72 hours after surgery

  10. T Lymphocyte cell DNA damage

    T lymphocyte cell count before fasting and after fasting

    Measured: During the first24、48 and 72 hours after surgery

  11. IL-1β,IL-2,IL-4,IL-5,IL-6,IL-8,IL-10,IL-17A,IL-17F,TNF-α,TNF-β,

    Inflammatory factor level

    Measured: During the first24、48 and 72 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2020
  2. Study start1 Jan 2020
  3. Primary completion30 Sep 2022 (estimated)
  4. Study completion30 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
2,400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04345978
Sponsor's protocol ID
B2020-063
Status last verified
Aug 2020
First submitted
8 Apr 2020
Last updated
11 Aug 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Fasting hours in people with Fasting and Immune Suppression, run by Fudan University at 7 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Disease-free Survival (time frame: During 2 years after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in